Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location. - Physician's Weekly


Advertisement

Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location.

Oct 09, 2023

ABOUT THE CONTRIBUTORS

  • Laura S Gold

    Department of Radiology, University of Washington, O1-140-6 UW Tower, 4333 Brooklyn Ave NE, Box 359558, Seattle, WA 98195-9558, United States. Electronic address: goldl@uw.edu.

    Ryan N Hansen

    School of Pharmacy, University of Washington, Seattle, WA, United States; Department of Health Services, University of Washington, Seattle, WA, United States.

    Sonya L Heltshe

    Department of Pediatrics, University of Washington, Seattle, WA, United States; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children’s Research Institute, Seattle, WA, United States.

    Patrick A Flume

    Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, SC, United States.

    Christopher H Goss

    Department of Pediatrics, University of Washington, Seattle, WA, United States; Department of Medicine, University of Washington, Seattle, WA, United States.

    Natalie E West

    Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.

    Don B Sanders

    Department of Pediatrics, Indiana University, Indianapolis, IN, United States.

    Larry Kessler

    Department of Health Services, University of Washington, Seattle, WA, United States.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.